These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26240978)

  • 41. Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome.
    Berginc G; Bracko M; Ravnik-Glavac M; Glavac D
    Fam Cancer; 2009; 8(4):421-9. PubMed ID: 19526325
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Elevated levels of the mismatch repair protein PMS2 are associated with prostate cancer.
    Norris AM; Woodruff RD; D'Agostino RB; Clodfelter JE; Scarpinato KD
    Prostate; 2007 Feb; 67(2):214-25. PubMed ID: 17044039
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multiple pilomatricomas with somatic CTNNB1 mutations in children with constitutive mismatch repair deficiency.
    Chmara M; Wernstedt A; Wasag B; Peeters H; Renard M; Beert E; Brems H; Giner T; Bieber I; Hamm H; Sciot R; Wimmer K; Legius E
    Genes Chromosomes Cancer; 2013 Jul; 52(7):656-64. PubMed ID: 23629955
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preoperative diagnosis of Lynch syndrome with DNA mismatch repair immunohistochemistry on a diagnostic biopsy.
    Warrier SK; Trainer AH; Lynch AC; Mitchell C; Hiscock R; Sawyer S; Boussioutas A; Heriot AG
    Dis Colon Rectum; 2011 Dec; 54(12):1480-7. PubMed ID: 22067175
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Selenium compounds activate ATM-dependent DNA damage response via the mismatch repair protein hMLH1 in colorectal cancer cells.
    Qi Y; Schoene NW; Lartey FM; Cheng WH
    J Biol Chem; 2010 Oct; 285(43):33010-33017. PubMed ID: 20709753
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epigenetic repression of DNA mismatch repair by inflammation and hypoxia in inflammatory bowel disease-associated colorectal cancer.
    Edwards RA; Witherspoon M; Wang K; Afrasiabi K; Pham T; Birnbaumer L; Lipkin SM
    Cancer Res; 2009 Aug; 69(16):6423-9. PubMed ID: 19638594
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interobserver variability in the evaluation of mismatch repair protein immunostaining.
    Klarskov L; Ladelund S; Holck S; Roenlund K; Lindebjerg J; Elebro J; Halvarsson B; von Salomé J; Bernstein I; Nilbert M
    Hum Pathol; 2010 Oct; 41(10):1387-96. PubMed ID: 20573374
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypothesis: Possible role of retinoic acid therapy in patients with biallelic mismatch repair gene defects.
    Gottschling S; Reinhard H; Pagenstecher C; Krüger S; Raedle J; Plotz G; Henn W; Buettner R; Meyer S; Graf N
    Eur J Pediatr; 2008 Feb; 167(2):225-9. PubMed ID: 17387511
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Response to ten Broeke and Nielsen.
    Lindor NM; Goodenberger ML
    Genet Med; 2015 Aug; 17(8):684-5. PubMed ID: 26240979
    [No Abstract]   [Full Text] [Related]  

  • 50. The E705K mutation in hPMS2 exerts recessive, not dominant, effects on mismatch repair.
    Deschênes SM; Tomer G; Nguyen M; Erdeniz N; Juba NC; Sepúlveda N; Pisani JE; Liskay RM
    Cancer Lett; 2007 May; 249(2):148-56. PubMed ID: 17029773
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Familial mutations in PMS2 can cause autosomal dominant hereditary nonpolyposis colorectal cancer.
    Worthley DL; Walsh MD; Barker M; Ruszkiewicz A; Bennett G; Phillips K; Suthers G
    Gastroenterology; 2005 May; 128(5):1431-6. PubMed ID: 15887124
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Childhood brain tumours due to germline bi-allelic mismatch repair gene mutations.
    Johannesma PC; van der Klift HM; van Grieken NC; Troost D; Te Riele H; Jacobs MA; Postma TJ; Heideman DA; Tops CM; Wijnen JT; Menko FH
    Clin Genet; 2011 Sep; 80(3):243-55. PubMed ID: 21261604
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Truncation of the mismatch repair protein PMS2 during the neoplastic transformation of human breast epithelial cells in vitro.
    Balogh GA; Russo IH; Russo J
    Int J Oncol; 2004 Aug; 25(2):381-7. PubMed ID: 15254735
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Apoptotic function of human PMS2 compromised by the nonsynonymous single-nucleotide polymorphic variant R20Q.
    Marinovic-Terzic I; Yoshioka-Yamashita A; Shimodaira H; Avdievich E; Hunton IC; Kolodner RD; Edelmann W; Wang JY
    Proc Natl Acad Sci U S A; 2008 Sep; 105(37):13993-8. PubMed ID: 18768816
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of mismatch repair gene PMS2 in nasopharyngeal carcinoma and regulation by glycogen synthase kinase-3β in vivo and in vitro.
    Fang J; Lei W; Huang X; Li P; Chen X; Zhu X; Wen W; Li H
    Auris Nasus Larynx; 2012 Feb; 39(1):71-6. PubMed ID: 21571466
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Four novel germline mutations in the MLH1 and PMS2 mismatch repair genes in patients with hereditary nonpolyposis colorectal cancer.
    Montazer Haghighi M; Radpour R; Aghajani K; Zali N; Molaei M; Zali MR
    Int J Colorectal Dis; 2009 Aug; 24(8):885-93. PubMed ID: 19479271
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Feasibility of screening for Lynch syndrome among patients with colorectal cancer.
    Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Clendenning M; Sotamaa K; Prior T; Westman JA; Panescu J; Fix D; Lockman J; LaJeunesse J; Comeras I; de la Chapelle A
    J Clin Oncol; 2008 Dec; 26(35):5783-8. PubMed ID: 18809606
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Café-au-lait macules and pediatric malignancy caused by biallelic mutations in the DNA mismatch repair (MMR) gene PMS2.
    Jackson CC; Holter S; Pollett A; Clendenning M; Chou S; Senter L; Ramphal R; Gallinger S; Boycott K
    Pediatr Blood Cancer; 2008 Jun; 50(6):1268-70. PubMed ID: 18273873
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Paediatric intestinal cancer and polyposis due to bi-allelic PMS2 mutations: case series, review and follow-up guidelines.
    Herkert JC; Niessen RC; Olderode-Berends MJ; Veenstra-Knol HE; Vos YJ; van der Klift HM; Scheenstra R; Tops CM; Karrenbeld A; Peters FT; Hofstra RM; Kleibeuker JH; Sijmons RH
    Eur J Cancer; 2011 May; 47(7):965-82. PubMed ID: 21376568
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A case of early onset rectal cancer of Lynch syndrome with a novel deleterious PMS2 mutation.
    Nomura S; Fujimoto Y; Yamamoto N; Sato Y; Ashihara Y; Kita M; Yamaguchi J; Ishikawa Y; Ueno M; Arai M
    Jpn J Clin Oncol; 2015 Oct; 45(10):987-92. PubMed ID: 26232782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.